Davide Bonanni

523 total citations
12 papers, 291 citations indexed

About

Davide Bonanni is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Davide Bonanni has authored 12 papers receiving a total of 291 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Cell Biology. Recurrent topics in Davide Bonanni's work include Histone Deacetylase Inhibitors Research (5 papers), Peptidase Inhibition and Analysis (4 papers) and Aldose Reductase and Taurine (3 papers). Davide Bonanni is often cited by papers focused on Histone Deacetylase Inhibitors Research (5 papers), Peptidase Inhibition and Analysis (4 papers) and Aldose Reductase and Taurine (3 papers). Davide Bonanni collaborates with scholars based in Italy, United Kingdom and Sweden. Davide Bonanni's co-authors include Giulio Rastelli, Luca Pinzi, Davide Moi, Andrea Citarella, Marco L. Lolli, Simonetta Oliaro‐Bosso, Elisabetta Marini, Donatella Boschi, Daniele Zonari and Agnese Chiara Pippione and has published in prestigious journals such as Journal of Medicinal Chemistry, RSC Advances and European Journal of Medicinal Chemistry.

In The Last Decade

Davide Bonanni

12 papers receiving 291 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Davide Bonanni Italy 8 169 93 48 44 38 12 291
Gurmit Grewal United States 9 222 1.3× 191 2.1× 41 0.9× 25 0.6× 32 0.8× 14 361
Arati Prabhu India 11 189 1.1× 108 1.2× 26 0.5× 54 1.2× 28 0.7× 28 318
Aikaterini Nikolaou Greece 9 196 1.2× 55 0.6× 31 0.6× 38 0.9× 44 1.2× 12 329
Sravan K. Jonnalagadda United States 11 161 1.0× 116 1.2× 52 1.1× 57 1.3× 31 0.8× 22 335
Jayapal Reddy Mallareddy United States 12 209 1.2× 45 0.5× 64 1.3× 12 0.3× 14 0.4× 27 346
Harumi Aono Japan 12 258 1.5× 44 0.5× 44 0.9× 27 0.6× 83 2.2× 25 392
Hemantkumar Deokar United States 11 228 1.3× 148 1.6× 60 1.3× 14 0.3× 47 1.2× 20 380
Leslie J. Askonas United States 10 116 0.7× 59 0.6× 47 1.0× 89 2.0× 30 0.8× 14 309
Hitoshi Sakashita Japan 10 220 1.3× 80 0.9× 50 1.0× 18 0.4× 30 0.8× 19 409
Jyotsna Bhat India 11 200 1.2× 30 0.3× 42 0.9× 26 0.6× 46 1.2× 16 320

Countries citing papers authored by Davide Bonanni

Since Specialization
Citations

This map shows the geographic impact of Davide Bonanni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Davide Bonanni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Davide Bonanni more than expected).

Fields of papers citing papers by Davide Bonanni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Davide Bonanni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Davide Bonanni. The network helps show where Davide Bonanni may publish in the future.

Co-authorship network of co-authors of Davide Bonanni

This figure shows the co-authorship network connecting the top 25 collaborators of Davide Bonanni. A scholar is included among the top collaborators of Davide Bonanni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Davide Bonanni. Davide Bonanni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Citarella, Andrea, Silvia Belluti, Davide Bonanni, et al.. (2025). Structure-Based Discovery of Hsp90/HDAC6 Dual Inhibitors Targeting Aggressive Prostate Cancer. Journal of Medicinal Chemistry. 68(15). 15738–15765. 1 indexed citations
2.
Moi, Davide, Davide Bonanni, Silvia Belluti, et al.. (2023). Discovery of potent pyrrolo-pyrimidine and purine HDAC inhibitors for the treatment of advanced prostate cancer. European Journal of Medicinal Chemistry. 260. 115730–115730. 14 indexed citations
3.
Bonanni, Davide, Luca Pinzi, & Giulio Rastelli. (2022). Development of machine learning classifiers to predict compound activity on prostate cancer cell lines. Journal of Cheminformatics. 14(1). 77–77. 5 indexed citations
4.
Moi, Davide, Andrea Citarella, Davide Bonanni, et al.. (2022). Synthesis of potent and selective HDAC6 inhibitors led to unexpected opening of a quinazoline ring. RSC Advances. 12(18). 11548–11556. 10 indexed citations
5.
Citarella, Andrea, Davide Moi, Luca Pinzi, Davide Bonanni, & Giulio Rastelli. (2021). Hydroxamic Acid Derivatives: From Synthetic Strategies to Medicinal Chemistry Applications. ACS Omega. 6(34). 21843–21849. 71 indexed citations
6.
Bonanni, Davide, et al.. (2021). Dual Targeting Strategies on Histone Deacetylase 6 (HDAC6) and Heat Shock Protein 90 (Hsp90). Current Medicinal Chemistry. 29(9). 1474–1502. 18 indexed citations
7.
Bonanni, Davide, Marco L. Lolli, & Jürgen Bajorath. (2020). Computational Method for Structure-Based Analysis of SAR Transfer. Journal of Medicinal Chemistry. 63(3). 1388–1396. 4 indexed citations
8.
Lolli, Marco L., Agnese Chiara Pippione, Weixiao Yuan Wahlgren, et al.. (2019). Bioisosteres of Indomethacin as Inhibitors of Aldo-Keto Reductase 1C3. ACS Medicinal Chemistry Letters. 10(4). 437–443. 37 indexed citations
9.
Sheldrake, Helen M., Davide Bonanni, Martina Daga, et al.. (2019). Exploration of [2 + 2 + 2] cyclotrimerisation methodology to prepare tetrahydroisoquinoline-based compounds with potential aldo–keto reductase 1C3 target affinity. MedChemComm. 10(8). 1476–1480. 3 indexed citations
10.
Chiarelli, Laurent R., Matteo Mori, Daniela Barlocco, et al.. (2018). Discovery and development of novel salicylate synthase (MbtI) furanic inhibitors as antitubercular agents. European Journal of Medicinal Chemistry. 155. 754–763. 57 indexed citations
11.
Pippione, Agnese Chiara, Davide Bonanni, Marcella Sini, et al.. (2018). Potent and selective aldo-keto reductase 1C3 (AKR1C3) inhibitors based on the benzoisoxazole moiety: application of a bioisosteric scaffold hopping approach to flufenamic acid. European Journal of Medicinal Chemistry. 150. 930–945. 40 indexed citations
12.
Pippione, Agnese Chiara, Davide Bonanni, Elisabetta Marini, et al.. (2017). Hydroxytriazole derivatives as potent and selective aldo-keto reductase 1C3 (AKR1C3) inhibitors discovered by bioisosteric scaffold hopping approach. European Journal of Medicinal Chemistry. 139. 936–946. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gurmit Grewal Breakdown of academic impact, for papers by Arati Prabhu Breakdown of academic impact, for papers by Aikaterini Nikolaou Breakdown of academic impact, for papers by Sravan K. Jonnalagadda Breakdown of academic impact, for papers by Jayapal Reddy Mallareddy Breakdown of academic impact, for papers by Harumi Aono Breakdown of academic impact, for papers by Hemantkumar Deokar Breakdown of academic impact, for papers by Leslie J. Askonas Breakdown of academic impact, for papers by Hitoshi Sakashita Breakdown of academic impact, for papers by Jyotsna Bhat
Rankless by CCL
2026